Sign in
4

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-22-001546

Director acquired 11,100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Keyes Jeffry R. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-03-07 Grant or award : show line 1 in the form +11,100 $0.30 $3,294 11,100 D
Loading xslF345X03/ownership.xml…